How is pharmacy stock planning different from normal retail forecasting?

For some categories, not only turnover is important, but also minimum availability, supply risks, validity and restrictions on where and how the stock can be moved. Therefore, sales history alone is insufficient.

Should the system automatically move supplies between pharmacies?

The analysis provides a transfer recommendation, its basis and the impact on the availability of other pharmacies. The physical movement is approved and carried out by the stock process, with professional and logistical restrictions.

How do you assess the addition of pharmacies while monitoring the deficiency and the risk of validity?

Time of critical product shortages, the proportion of surplus or near-expiry stocks, and the number of emergency manual transfers. These indicators better show the outcome of planning than a mere forecast error.

What data to add to the history of pharmacy sales?

It is necessary to know when the goods were not available, what quantity customers did not receive, real delivery terms and product management restrictions. The interchangeability of medicines cannot be determined solely by similar price or sales behaviour; for this purpose, approved professional data are used.

Pharmacy network demand and inventory analytics system

The planner evaluates the demand, supply terms and validity of pharmacies. Addition and distribution decisions take into account the need for critical products and the restrictions imposed.

Seasonal demand, supply disruptions, substitutability of prescription and non-prescription products, and validity risks are assessed separately. Some locations lack important products, while others accumulate stocks that are slow to move or expire.

How the solution works

The planner identifies products for which minimum availability is important and restrictions on their supply.
Sales history is compared to periods of scarcity, validity and balances in each pharmacy.
The proposed addition or allowable relocation is assessed in conjunction with the impact on the availability of other locations.
The approved action is transferred for execution; the time of the defect and the unused balance are then compared.

Key challenges

Demand and validity planning not sufficiently linked

Solution capabilities

Demand in a specific pharmacy

The planner assesses the need for a location, distinguishing low demand from the inability to sell due to scarcity.

Limits of Accessibility

The level set for critical goods is comparable to the supply risk and real replenishment time.

Permitted redistribution

The transfer recommendation explains the need at the recipient's location, the balance at the sender's location, and the restrictions on product transfer.

Remaining shelf life

The planned quantity is measured by expected use over the remaining time; physical control of validity and recall is carried out by a dedicated process.

Business context

Demand and validity planning not sufficiently linked: Seasonal demand, supply disruptions, substitutability of prescription and non-prescription products, and validity risks are assessed separately. Some locations lack important products, while others accumulate stocks that are slow to move or expire.
Availability is planned according to location-specific need: The product missing from the customer can mean an additional trip or wait. Combining demand with supply and validity, individual pharmacies can be more accurately supplied. Decisions are judged on the availability of goods and the risk of unused stock, subject to applicable distribution restrictions.

Core features

Demand in a specific pharmacy
Limits of Accessibility
Permitted redistribution
Remaining shelf life

Key integrations

POS / ERP: Location sales, balances, orders and a history of shortages.
WMS / Network Stock System: Warehouse and pharmacy supplies, transfers and ordered stock.
batch and Validity System: Risks of validity and batch restrictions where relevant to the transfer recommendation.
Supply data: The supplier term, disorders and other factors limiting availability.

Potential impact (%)

The ranges indicate an illustrative relative change in the metric under the stated assumptions. Results depend on the starting position and actual use of the solution. Percentages for different metrics must not be added together.

Time of critical product shortage in selected pharmacies

2–12%Decreasing

This illustrative scenario assumes that 10-30% of the metric is attributable to addressable planning and execution shortcomings. That share is assumed to fall by 20-40%. Company data is needed to verify both the addressable share and the resulting change.

Counting selected goods and pharmacy days without the right stock to sell. Separately mark external supply disruptions and maintain the same set of critical goods.

Proportion of emergency hand stock transfers between pharmacies

12–42%Decreasing

This illustrative scenario assumes that 30-60% of errors can be addressed through the data and rule checks described. That share is assumed to fall by 40-70%. Company data is needed to verify both the addressable share and the resulting change.

Transfers initiated as a matter of urgency due to an impending or already existing shortfall are counted. The percentage is calculated on the number of total transfers of stocks.

Conditional calculation scenarios. The assumptions have not been validated against client measurements.

When this solution is relevant

Seasonal demand, supply disruptions, substitutability of prescription and non-prescription products and validity risks are assessed separately
Some locations lack important products, while others accumulate slowly moving or ending stock

Implementation requirements

Pharmacy stock analysts prepare actual periods of shortages, reliability and validity of supply. Transfer criteria must assess the need for both pharmacies and professional and logistical constraints before a decision is made to approve.